| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
An antineoplastic agent that acts by alkylation. [PubChem] |
| Indication |
For the treatment of polycythaemia vera and refractory chronic myeloid leukaemia. |
| Pharmacology |
Pipobroman is an antineoplastic agent. Specifically it is a piperazine derivative with a chemical structure close to that of many DNA alkylating agents. Pipobroman has well documented clinical activity against polycythemia vera and essential thrombocythemia. |
| Toxicity |
Symptoms of overdose include hematologic toxicity, especially with chronic overdosage. |
| Affected Organisms |
| • |
Humans and other mammals |
|
| Absorption |
Well absorbed from the GI tract. |
| External Links |
|